1. retinal eye disease 2. known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency 3. known chronic kidney disease, stage 4 or 5 or receiving dialysis 4. current use of: * class 3 aad - amiodarone, dronaderone, dofetilide, sotalol) * class 1a aad (procainamide, quinidine, disopyramide) * flecainide * chlorpromazine * cilostazol (pletal) * donepezil (aricept) * droperidol * fluconazole * methadone * ondansetron(zofran) * thioridazine * macrolides (clarithromycin, erythromycin) * fluroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) 5. pregnancy or women who are breast feeding 6. inability to tolerate oral medications 7. allergy or prior adverse reaction to either azithromycin or hydroxychloroquine sulfate 8. allergy to adhesives 9. qtc interval \> 450 msec for men and women 10. history of torsade de pointes vt or prior cardiac arrest or congenital long qt interval 11. non-english-speaking

1. retinal eye disease 2. known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency 3. known chronic kidney disease, stage 4 or 5 or receiving dialysis 4. current use of: * class 3 aad - amiodarone, dronaderone, dofetilide, sotalol) * class 1a aad (procainamide, quinidine, disopyramide) * flecainide * chlorpromazine * cilostazol (pletal) * donepezil (aricept) * droperidol * fluconazole * methadone * ondansetron(zofran) * thioridazine * macrolides (clarithromycin, erythromycin) * fluroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) 5. pregnancy or women who are breast feeding 6. inability to tolerate oral medications 7. allergy or prior adverse reaction to either azithromycin or hydroxychloroquine sulfate 8. allergy to adhesives 9. qtc interval \> 450 msec for men and women 10. history of torsade de pointes vt or prior cardiac arrest or congenital long qt interval 11. non-english-speaking

retinal eye disease known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency known chronic kidney disease, stage 4 or 5 or receiving dialysis current use of: class 3 aad - amiodarone, dronaderone, dofetilide, sotalol) class 1a aad (procainamide, quinidine, disopyramide) flecainide chlorpromazine cilostazol (pletal) donepezil (aricept) droperidol fluconazole methadone ondansetron(zofran) thioridazine macrolides (clarithromycin, erythromycin) fluroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) pregnancy or women who are breast feeding inability to tolerate oral medications allergy or prior adverse reaction to either azithromycin or hydroxychloroquine sulfate allergy to adhesives qtc interval > 450 msec for men and women history of torsade de pointes vt or prior cardiac arrest or congenital long qt interval non-english-speaking

retinal eye disease known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency known chronic kidney disease, stage 4 or 5 or receiving dialysis current use of: class 3 aad - amiodarone, dronaderone, dofetilide, sotalol) class 1a aad (procainamide, quinidine, disopyramide) flecainide chlorpromazine cilostazol (pletal) donepezil (aricept) droperidol fluconazole methadone ondansetron(zofran) thioridazine macrolides (clarithromycin, erythromycin) fluroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) pregnancy or women who are breast feeding inability to tolerate oral medications allergy or prior adverse reaction to either azithromycin or hydroxychloroquine sulfate allergy to adhesives qtc interval > 450 msec for men and women history of torsade de pointes vt or prior cardiac arrest or congenital long qt interval non-english-speaking

1. retinal eye disease 2. known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency 3. known chronic kidney disease, stage 4 or 5 or receiving dialysis 4. current use of: - class 3 aad - amiodarone, dronaderone, dofetilide, sotalol) - class 1a aad (procainamide, quinidine, disopyramide) - flecainide - chlorpromazine - cilostazol (pletal) - donepezil (aricept) - droperidol - fluconazole - methadone - ondansetron(zofran) - thioridazine - macrolides (clarithromycin, erythromycin) - fluroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) 5. pregnancy or women who are breast feeding 6. inability to tolerate oral medications 7. allergy or prior adverse reaction to either azithromycin or hydroxychloroquine sulfate 8. allergy to adhesives 9. qtc interval > 450 msec for men and women 10. history of torsade de pointes vt or prior cardiac arrest or congenital long qt interval 11. non-english-speaking

1. retinal eye disease 2. known glucose-6 phosphate dehydrogenase (g-6-pd) deficiency 3. known chronic kidney disease, stage 4 or 5 or receiving dialysis 4. current use of: - class 3 aad - amiodarone, dronaderone, dofetilide, sotalol) - class 1a aad (procainamide, quinidine, disopyramide) - flecainide - chlorpromazine - cilostazol (pletal) - donepezil (aricept) - droperidol - fluconazole - methadone - ondansetron(zofran) - thioridazine - macrolides (clarithromycin, erythromycin) - fluroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) 5. pregnancy or women who are breast feeding 6. inability to tolerate oral medications 7. allergy or prior adverse reaction to either azithromycin or hydroxychloroquine sulfate 8. allergy to adhesives 9. qtc interval > 450 msec for men and women 10. history of torsade de pointes vt or prior cardiac arrest or congenital long qt interval 11. non-english-speaking